Non-Syndromic Hearing Impairment Protein 5 (GSDME) (AA 1-152) antibody
Quick Overview for Non-Syndromic Hearing Impairment Protein 5 (GSDME) (AA 1-152) antibody (ABIN7113358)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-152
-
Purpose
- GSDME antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
-
Immunogen sequence: 1-152aa
Immunogen: deafness, autosomal dominant 5
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500 - 1:2000, IHC: 1:50 - 1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months
-
Expiry Date
- 12 months
-
-
- Non-Syndromic Hearing Impairment Protein 5 (GSDME)
-
Alternative Name
- GSDME
-
Background
-
Synonyms: Gasdermin-E|Inversely correlated with estrogen receptor expression 1 (ICERE-1)|Non-syndromic hearing impairment protein 5|Gasdermin-E, N-terminal (GSDME-NT)|Gasdermin-E, C-terminal (GSDME-CT)|GSDME|DFNA5|ICERE1
Background: Hearing impairment is a heterogeneous condition with over 40 loci described. The protein encoded by this gene is expressed in fetal cochlea, however, its function is not known. Nonsyndromic hearing impairment is associated with a mutation in this gene. Three transcript variants encoding two different isoforms have been found for this gene.
-
Molecular Weight
- 54 kDa
-
Gene ID
- 1687
-
UniProt
- O60443
Target
-